Australia markets close in 1 hour 20 minutes

Windtree Therapeutics, Inc. (WINT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.8750-0.0650 (-1.32%)
At close: 04:00PM EDT
5.0000 +0.12 (+2.56%)
After hours: 06:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.49M
Enterprise value -1.88k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)660.53
Price/book (mrq)0.73
Enterprise value/revenue 706.08
Enterprise value/EBITDA 0.00

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3-84.04%
S&P500 52-week change 324.49%
52-week high 335.1000
52-week low 34.1800
50-day moving average 36.3928
200-day moving average 314.1910

Share statistics

Avg vol (3-month) 319.07k
Avg vol (10-day) 368.78k
Shares outstanding 5510.18k
Implied shares outstanding 6516.98k
Float 8451.21k
% held by insiders 14.66%
% held by institutions 112.91%
Shares short (15 Apr 2024) 42.58k
Short ratio (15 Apr 2024) 40.35
Short % of float (15 Apr 2024) 40.51%
Short % of shares outstanding (15 Apr 2024) 40.51%
Shares short (prior month 15 Mar 2024) 41.69k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 329 Apr 2020
Ex-dividend date 4N/A
Last split factor 21:18
Last split date 322 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-29.92%
Return on equity (ttm)-302.78%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -16.76M
Net income avi to common (ttm)-20.29M
Diluted EPS (ttm)-94.3200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.32M
Total cash per share (mrq)8.47
Total debt (mrq)16.83M
Total debt/equity (mrq)496.31%
Current ratio (mrq)1.35
Book value per share (mrq)10.18

Cash flow statement

Operating cash flow (ttm)-13.44M
Levered free cash flow (ttm)-7.54M